SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice.
Wilding J, Fernando K, Milne N, Evans M, Ali A, Bain S, Hicks D, James J, Newland-Jones P, Patel D, Viljoen A.
Wilding J, et al. Among authors: evans m.
Diabetes Ther. 2018 Oct;9(5):1757-1773. doi: 10.1007/s13300-018-0471-8. Epub 2018 Jul 23.
Diabetes Ther. 2018.
PMID: 30039249
Free PMC article.
Review.